Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-infected individuals in Rakai, Uganda

Journal of NeuroVirology

Volumn 23, Issue 3, 2017, Pages 369-375

  Abassi, Mahsa ^a,b   Morawski, Bozena M ^a,b   Nakigozi, Gertrude ^c   Nakasujja, Noeline ^b,d   Kong, Xiangrong ^e   Meya, David B ^a,b,d   Robertson, Kevin ^f   Gray, Ronald ^e   Wawer, Maria J ^e   Sacktor, Ned ^g   Boulware, David R ^a  

^a UNIVERSITY OF MINNESOTA   (United States)

^b MULAGO HOSPITAL   (Uganda)

^c RAKAI HEALTH SCIENCES PROGRAM   (Uganda)

^d MAKERERE UNIVERSITY   (Uganda)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^f UNIVERSITY OF NORTH CAROLINA   (United States)

^g JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Cytokine expression; Dementia; HIV associated neurocognitive disorders; Inflammation; Neurodegenerative biomarkers

Indexed keywords

ADVANCED GLYCATION END PRODUCT RECEPTOR; AMYLOID BETA PROTEIN[1-42]; BIOLOGICAL MARKER; BRAIN DERIVED NEUROTROPHIC FACTOR; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; INTERLEUKIN 12; INTERLEUKIN 1BETA; INTERLEUKIN 2; INTERSTITIAL COLLAGENASE; MATRILYSIN; PLATELET DERIVED GROWTH FACTOR AA; PROTEIN S100B; STROMELYSIN 2; TUMOR NECROSIS FACTOR; AMYLOID BETA PROTEIN; AMYLOID BETA-PROTEIN (1-42); BRAIN-DERIVED NEUROTROPHIC FACTOR, HUMAN; MMP1 PROTEIN, HUMAN; MMP7 PROTEIN, HUMAN; PEPTIDE FRAGMENT; PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR A; S100B PROTEIN, HUMAN; SRAGE PROTEIN, HUMAN;

ADULT; ARTICLE; CD4 LYMPHOCYTE COUNT; CEREBROSPINAL FLUID ANALYSIS; CLINICAL ARTICLE; DISEASE ASSOCIATION; FEMALE; HIV ASSOCIATED DEMENTIA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTED PATIENT; IMMUNOSUPPRESSIVE TREATMENT; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; UGANDA; BLOOD; CD4+ T LYMPHOCYTE; CEREBROSPINAL FLUID; IMMUNOLOGY; MIDDLE AGED; NEUROPSYCHOLOGICAL TEST; PATHOLOGY; PATHOPHYSIOLOGY; PROSPECTIVE STUDY;

ADULT; AIDS DEMENTIA COMPLEX; AMYLOID BETA-PEPTIDES; BIOMARKERS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; FEMALE; GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; HUMANS; INTERLEUKIN-12; INTERLEUKIN-2; MALE; MATRIX METALLOPROTEINASE 1; MATRIX METALLOPROTEINASE 7; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PEPTIDE FRAGMENTS; PLATELET-DERIVED GROWTH FACTOR; PROSPECTIVE STUDIES; RECEPTOR FOR ADVANCED GLYCATION END PRODUCTS; S100 CALCIUM BINDING PROTEIN BETA SUBUNIT; TUMOR NECROSIS FACTOR-ALPHA; UGANDA;

EID: 85006354659     PISSN: 13550284     EISSN: 15382443     Source Type: Journal    
DOI: 10.1007/s13365-016-0505-9     Document Type: Article

References (27)

1. Antinori A, Arendt G, Becker JT, Brew BJ, Byrd DA, Cherner M, Clifford DB, Cinque P, Epstein LG, Goodkin K, Gisslen M, Grant I, Heaton RK, Joseph J, Marder K, Marra CM, McArthur JC, Nunn M, Price RW, Pulliam L, Robertson KR, Sacktor N, Valcour V, Wojna VE (2007) Updated research nosology for HIV-associated neurocognitive disorders. Neurology 69(18):1789–1799
2. Bachis A, Avdoshina V, Zecca L, Parsadanian M, Mocchetti I (2012) Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons. J Neurosci 32(28):9477–9484
3. Bierhaus A, Humpert PM, Morcos M, Wendt T, Chavakis T, Arnold B, Stern DM, Nawroth PP (2005) Understanding RAGE, the receptor for advanced glycation end products. J Mol Med (Berl) 83(11):876–886
4. Blasko I, Veerhuis R, Stampfer-Kountchev M, Saurwein-Teissl M, Eikelenboom P, Grubeck-Loebenstein B (2000) Costimulatory effects of interferon-gamma and interleukin-1beta or tumor necrosis factor alpha on the synthesis of Abeta1-40 and Abeta1-42 by human astrocytes. Neurobiol Dis 7(6 Pt B):682–689
5. Brett J, Schmidt AM, Yan SD, Zou YS, Weidman E, Pinsky D, Nowygrod R, Neeper M, Przysiecki C, Shaw A et al (1993) Survey of the distribution of a newly characterized receptor for advanced glycation end products in tissues. Am J Pathol 143(6):1699–1712
6. Brew BJ, Pemberton L, Blennow K, Wallin A, Hagberg L (2005) CSF amyloid beta 42 and tau levels correlate with AIDS dementia complex. Neurology 65(9):1490–1492
7. Clifford DB, Ances BM (2013) HIV-associated neurocognitive disorder. Lancet Infect Dis 13(11):976–986
8. Conant K, McArthur JC, Griffin DE, Sjulson L, Wahl LM, Irani DN (1999) Cerebrospinal fluid levels of MMP-2, 7, and 9 are elevated in association with human immunodeficiency virus dementia. Ann Neurol 46(3):391–398
9. Deane R, Yan SD, Submamaryan RK, LaRue B, Jovanovic S, Hogg E, Welch D, Manness L, Lin C, Yu J, Zhu H, Ghiso J, Frangione B, Stern A, Schmidt AM, Armstrong DL, Arnold B, Liliensiek B, Nawroth P, Hofman F, Kindy M, Stern D, Zlokovic B (2003) RAGE mediates amyloid-beta peptide transport across the blood-brain barrier and accumulation in brain. Nat Med 9(7):907–913
10. Emanuele E, D’Angelo A, Tomaino C, Binetti G, Ghidoni R, Politi P, Bernardi L, Maletta R, Bruni AC, Geroldi D (2005) Circulating levels of soluble receptor for advanced glycation end products in Alzheimer disease and vascular dementia. Arch Neurol 62(11):1734–1736
11. Everall IP, Luthert PJ, Lantos PL (1993) Neuronal number and volume alterations in the neocortex of HIV infected individuals. J Neurol Neurosurg Psychiatry 56(5):481–486
12. Grabowski MK, Lessler J, Redd AD, Kagaayi J, Laeyendecker O, Ndyanabo A, Nelson MI, Cummings DA, Bwanika JB, Mueller AC, Reynolds SJ, Munshaw S, Ray SC, Lutalo T, Manucci J, Tobian AA, Chang LW, Beyrer C, Jennings JM, Nalugoda F, Serwadda D, Wawer MJ, Quinn TC, Gray RH, P. Rakai Health Sciences (2014) The role of viral introductions in sustaining community-based HIV epidemics in rural Uganda: evidence from spatial clustering, phylogenetics, and egocentric transmission models. PLoS Med 11(3):e1001610
13. Green DA, Masliah E, Vinters HV, Beizai P, Moore DJ, Achim CL (2005) Brain deposition of beta-amyloid is a common pathologic feature in HIV positive patients. AIDS 19(4):407–411
14. Li Y, Wang J, Sheng JG, Liu L, Barger SW, Jones RA, Van Eldik LJ, Mrak RE, Griffin WS (1998) S100 beta increases levels of beta-amyloid precursor protein and its encoding mRNA in rat neuronal cultures. J Neurochem 71(4):1421–1428
15. Nottet HS, Persidsky Y, Sasseville VG, Nukuna AN, Bock P, Zhai QH, Sharer LR, McComb RD, Swindells S, Soderland C, Gendelman HE (1996) Mechanisms for the transendothelial migration of HIV-1-infected monocytes into brain. J Immunol 156(3):1284–1295
16. Park IH, Yeon SI, Youn JH, Choi JE, Sasaki N, Choi IH, Shin JS (2004) Expression of a novel secreted splice variant of the receptor for advanced glycation end products (RAGE) in human brain astrocytes and peripheral blood mononuclear cells. Mol Immunol 40(16):1203–1211
17. Pemberton LA, Brew BJ (2001) Cerebrospinal fluid S-100beta and its relationship with AIDS dementia complex. J Clin Virol 23:249–253
18. Perrella O, Guerriero M, Izzo E, Soscia M, Carrieri PB (1992) Interleukin-6 and granulocyte macrophage-CSF in the cerebrospinal fluid from HIV infected subjects with involvement of the central nervous system. Arq Neuro-Psiquiat 50(2):180–182
19. Peskind ER, Griffin WST, Akama KT, Raskind MA, Van Eldik LJ (2001) Cerebrospinal fluid S100B is elevated in the earlier stages of Alzheimer’s disease. Neurochem Int 39(5–6):409–413
20. Rao VR, Ruiz AP, Prasad VR (2014) Viral and cellular factors underlying neuropathogenesis in HIV associated neurocognitive disorders (HAND). AIDS Res Ther 11:13
21. Resnick L, Berger JR, Shapshak P, Tourtellotte WW (1988) Early penetration of the blood-brain-barrier by HIV. Neurology 38(1):9–14
22. Sacktor NC, Wong M, Nakasujja N, Skolasky RL, Selnes OA, Musisi S, Robertson K, McArthur JC, Ronald A, Katabira E (2005) The International HIV Dementia Scale: a new rapid screening test for HIV dementia. AIDS 19(13):1367–1374
23. Stanley LC, Mrak RE, Woody RC, Perrot LJ, Zhang S, Marshak DR, Nelson SJ, Griffin WST (1994) Glial cytokines as neuropathogenic factors in HIV infection: pathogenic similarities to Alzheimer’s disease. J Neuropathol Exp Neurol 53(3):231–238
24. Steiner J, Bogerts B, Schroeter ML, Bernstein HG (2011) S100B protein in neurodegenerative disorders. Clin Chem Lab Med 49(3):409–424
25. Wawer MJ, Sewankambo NK, Serwadda D, Quinn TC, Paxton LA, Kiwanuka N, Wabwire-Mangen F, Li C, Lutalo T, Nalugoda F, Gaydos CA, Moulton LH, Meehan MO, Ahmed S, Gray RH (1999) Control of sexually transmitted diseases for AIDS prevention in Uganda: a randomised community trial. Rakai Project Study Group. Lancet 353(9152):525–535
26. Xu J, Ikezu T (2009) The comorbidity of HIV-associated neurocognitive disorders and Alzheimer’s disease: a foreseeable medical challenge in post-HAART era. J NeuroImmune Pharmacol 4(2):200–212
27. Yao H, Bethel-Brown C, Niu F, Yang L, Peng F, Buch S (2014) Yin and yang of PDGF-mediated signaling pathway in the context of HIV infection and drug abuse. J NeuroImmune Pharmacol 9(2):161–167